Management of giant liver hemangiomas: an update. (March 2013)

• Record Type: Journal Article
• Authors: Hoekstra, Lisette T; Bieze, Matthanja; Erdogan, Deha; Roelofs, Joris JTH; Beuers, Ulrich HW; Gulik, Thomas M van
• Is Part Of: Expert review of gastroenterology & hepatology. Volume 7:Number 3(2013)
• Page Start: 263
• Page End: 268
• Publication Date: 2013-03
• Subjects: enucleation -- giant liver hemangiomas -- imaging -- resection -- symptoms; Gastroenterology -- Periodicals; Liver -- Diseases -- Periodicals; 616.3
• DOI: 10.1586/egh.13.10
• Languages: English
• ISSNs: 1747-4124

Abstract

Liver hemangiomas are the most common benign liver tumors and are usually incidental findings. Liver hemangiomas are readily demonstrated by abdominal ultrasonography, computed tomography or magnetic resonance imaging. Giant liver hemangiomas are defined by a diameter larger than 5 cm. In patients with a giant liver hemangioma, observation is justified in the absence of symptoms. Surgical resection is indicated in patients with abdominal (mechanical) complaints or complications, or when diagnosis remains inconclusive. Enucleation is the preferred surgical method, according to existing literature and our own experience. Spontaneous or traumatic rupture of a giant hepatic hemangioma is rare, however, the mortality rate is high (36–39%). An uncommon complication of a giant hemangioma is disseminated intravascular coagulation (Kasabach–Merritt syndrome); intervention is then required. Herein, the authors provide a literature update of the current evidence concerning the management of giant hepatic hemangiomas. In addition, the authors assessed treatment strategies and outcomes in a series of patients with giant liver hemangiomas managed in our department.